INTRODUCTION
The adrenergic innervation of the gastrointestinal tract generally has an inhibitory effect on motor function (1) . Howev-er, the internal anial (2) , choledochal (3, 4) , ileocecal (5, 6), and lower esophageal sphincters (7-9) (LES) ' have been shown to have alpha adrenergic receptors, the stimulation of which produces an excitatory effect. Beta adrenergic stimulation at these sphincters still produces an inhibitory response. It had been suggested through studies in vitro that the excitatory response mediated through alpha adrenergic stimuilation at the LES may be an important factor in the genesis of sphincter pressure (7) . Tn addition. it 1-min interval from the portion of the sphincter demonstrating the highest pressure. Mean LES pressure was obtained by determining the stable pressure at a minimum of four points during a 1-min period. Blood pressure was measured as the mean pressure obtained over a 1-min interval. Swallowing was induced by gently touching the cricoid cartilage.
Control values of LES pressure, percent of relaxation of the LES with swallowing, and blood pressure were obtained after insertion of the intravenous and intra-arterial cannulas and before the instillation of drugs. A period of 30 min for stabili7ation to baseline levels was observed after the administration of each pharmacological agent.
The following pharmacological agents were given intravenously as 30-s boluses: norepinephrine (0.025 ,ug/kg-72.0 /Ag/kg), isoproterenol (0.001 ,ug/kg-14.0 Ag/kg), phenylephrine (55.0 ,ug/kg), and epinephrine (60 ,g/kg). The beta adrenergic antagonist, propranolol (0.2 mg/kg-2.0 mg/ kg) and the alpha adrenergic antagonist, phentolamine (0.5 mg/kg-1.5 mg/kg) were also administered. The selections of doses of drugs were initially based on the recognized predictable effects on blood pressure and pulse rates of the animals. Drugs were given in random order and at random doses with agonists and antagonists given on separate days. Each drug was diluted in normal saline and administered as a 2.0-cm3 injection. Isoproterenol was diluted in 5% dextrose and water and given at the same volume.
Sympathetic denervation was obtained with 6-hydroxydopamine at a dose of 100 mg/kg given intraperitoneally. The compound, 6-hydroxydopamine, had been shown to cause destructicn of adrenergic nerves at several anatomic locations (11) (12) (13) (14) . Previous studies have shown that a single i.p. injection of 16.5 mg/kg of 6-hydroxydopamine produced adrenergic nerve destruction, which was maximal at 24 h and lasted for several weeks (12) . All studies were performed 24-96 h after i.p. injection. In eight animals, the mean LES pressure and the percent relaxation in LES pressure during swallowing was noted both before and after 6-hydroxydopamine injection in the same animal. Since a major determinant of LES pressure is endogenous gastrin, the effect of adrenergic agents upon serum gastrin levels was evaluated. In five animals, the basal serum gastrin level and the gastrin levels after 6-hydroxydopamine and norepinephrine were determined by the standard doubleantibody technique as utilized previously in this animal model (15) . In addition, the LES response to exogenous gastrin I (residue 2-17, Hexadecapeptide amide, Imperial Chemical Industries Ltd., Alderley Park, Cheshire, England) was evaluated in five control animals and in five animals given 6-hydroxydopamine. The dose of gastrin I shown previously to give a maximal LES response was used (15) . Gastrin was administered as a single 30-s intravenous injection.
Statistical analysis was performed using the Student ttest.
RESULTS
In 31 animals intraluminal manometry demonstrated the presence of a 1.5+0.2-cm (mean±SEM) zone of elevated pressure at the junction of esophagus and stomach. The mean midrespiratory pressure within this zone was 36.3±3.1 mm Hg above intra-abdominal pressure. A consistent decrease in pressure was recorded fronm this zone when deglutition was initiated. This zonie of elevated pressure represented the LES.
In Fig. 1 decrease in LES pressure.
In Fig. 2 , the LES and blood pressure responses for 10 animals are sunmmarized. These responses differed for drugs with pure alpha effect (phenylephrine), predominantly alpha effect (norepinephrine), pure beta effect (isoproterenol), and a mixed effect (epinephrine). These studies indicated that drugs acting at alpha receptors increased both LES and blood pressure whereas drugs acting at beta receptors gave an opposite effect. These studies demonstrated the general nature of the response to each type of compound, and that chalniges in blood pressure and LES pressure can be dissociated, as with epinephrine. To evaluate the adrenergic regulation of the LES further, eight animals were studied before and after sympathetic denervation with 6-hydroxydopamine. After the administration of 6-hydroxydopamine, LES pressure was reduced from 39.6±4.4 mm Hg to 30.7±2.3 mm Hg, as shown in Fig. 4 . This 22.5±5.3% reduction in LES pressure was statistically significant (P < 0.025). After 6-hydroxydopamine the percent relaxation during swallowing was unaltered (P > 0.05). Thus, destruction of the adrenergic nerves by 6-hydroxydopamine gave a small reduction in resting LES pressure and no alteration in the LES response to swallowing. However, the decrease in LES pressure after 6-hydroxydopamine was significantly less than that obtained after intravenous phentolamine (P < 0.01). The discrepancy in the magnitude of response to 6-hydroxydopamine and phentolamine (1.5 mg/kg) was not readily explained. Two possibilities were considered. First, an acquired supersensitivity to adrenergic stimulation through circulating catecholamines after denervation may account for the greater reduction in LES pressure with phentolamine. Second, the 6-hydroxydopamine produced only a partial destruction of adrenergic nerves with the esophagus. Each possibility was studied.
In Fig. 5 are shown the dose response curves for both LES and blood pressure to norepinephrine in controls and animals given 6-hydroxydopamine. The LES response to norepinephrine in denervated animals was more sensitive than in controls. The threshold response and the steeply sloped linear portion of the dose response curve was shifted to the left. The maximal (126.8±29.8 mm Hg), did not differ from the change in blood pressure in 6-hydroxydopamine-treated animals, 202.3±52.3% (105.4±27.3 mm Hg). Thus, the reduction in LES pressure after 6-hydroxydopamine may be diminished by an increased sensitivity to catecholamines. In six denervated animals, phentolamine (1.5 mg/kg) reduced LES pressure by 18.6±3.2% (P < 0.01), suggesting that an adrenergic effect was still present at the LES.
To determine the effect of denervation on beta adrenergic stimulation, animals treated with 6-hydroxydopamine were evaluated in response to isoproterenol. As shown in Fig. 6 , the LES and blood pressure dose response curves were unaltered after denervation. At each dose of isoproterenol, the percents of reduction in both LES pressure and blood pressure were similar.
The above studies with 6-hydroxydopamine demonstrated the dose response characteristics of the LES to be consistent with a denervation supersensitivity for alpha but not beta adrenergic agonists. However, these findings did not resolve the question as to whether the discrepancy in the reduction in basal LES pressure after 6-hydroxydopamine and phentolamine was due to
The FIGURE 5 Norepinephrine dose-response curves for LES pressure and arterial pressure in controls and animals given 6-hydroxydopamine. Each point represents the mean±SEM of the percent change in pressure for eight animals. In aniimals given 6-hydroxydopamine, the entire LES and arterial pressure dose-response curves were shifted to the left. The threshold and maximum response occurred at lower doses in denervated animals. The maximal percent increases in bothl LES and blood pressure were similar. The dose of norepinephrine that gave a response equal to half of the maximal response (effective dose 50) was lowered significantly for both the LES and blood pressure responises in animals given 6-hydroxydopamine. 6 Isoproterenol dose response curves for LES pressure and arterial blood pressure in controls and animals given 6-hydroxydopamine. Each point represents the mean+SEM of the percent change in pressure for eight animals. The dose-response curves for both LES pressure and blood pressure in denervated animals were similar to controls at each dose. mine (P < 0.01). Thus, tissue norepinephrine was reduced to 4.7% of control after 6-hydroxydopamine. This magnitude of change was reported previously in tissues demonstrated to have a high degree of nerve destruction (12) .
The serum gastrin level in five control animals was 162.3±18.6 pg/ml, as compared with 158.7+20.3 pg/ml in five animals given 6-hydroxydopamine (P > 0.05).
The basal serum gastrin level of 162.3±i18.6 pg/ml was decreased to 144.9±24.6 pg/ml after the intravenous administration of norepinephrine, 3.5 tg/kg (P > 0.05).
The maximal LES response to exogenous gastrin I at 1.0 Ag/kg was similar in controls, 83.2+10.1 mm Hg, as obtained in animals given 6-hydroxydopamine, 79.5 ±-9.6 mm Hg (P > 0.05). These findings suggested that neither 6-hydroxydopamine nor exogenous norepinephrine changed the level of endogenous gastrin. Adrenergic denervation did not alter the LES response to exogenous gastrin I. DISCUSSION The action of adrenergic compounds on esophageal and LES smooth muscle had been previously investigated in vitro (7) (8) (9) . The unique effect of alpha adrenergic stimulation of esophageal muscle and the greater sensitivity of LES muscle to alpha adrenergic agents suggested that these nerves may play a major role in the genesis of sphincter pressure (7) . In addition, it had been suggested that beta receptor stimulation mediated sphincteric relaxation during swallowing (10) . The purpose of this study was to investigate the adrenergic responses of the LES and to quantify the role of the adrenergic neural system in the genesis of LES pressure and in the inhibitory response to swallowing. The results of these studies suggested: (a) the alpha adrenergic receptors of the LES mediated contraction whereas the beta receptors mediated inhibition, and both responses were dose-related; (b) in the basal state, a significant portion of LES pressure was dependent upon alpha adrenergic stimulation, but beta adrenergic responses had no role in either basal LES pressure or LES relaxation during swallowing; (c) adrenergic denervation with 6-hydroxydopamine produced a supersensitivity to alpha but not beta adrenergic stimulation.
Although the response of esophageal muscle to adrenergic compounds had been studied in vitro (7) (8) (9) , the contribution of the adrenergic neural system to the genesis of basal LES pressure was undetermined by accurate recording techniques and pharmacological intervention. In an extensive review of the older literature, nonpharmacological studies of adrenergic effects on the esophagus in a variety of species gave conflicting results (16) . However, most studies did indicate that sympathetic nerve stimulation gave "spasm" of the LES in man, monkey, dog, and cat. Conversely, sympathectomy or stellate ganglion block could produce a patulous distal esophagus. Clear-cut findings were not agreed upon in all studies (16) . More recent studies in vivo suggested that LES competence was due mainly to endogenous gastrin (15) . Passive transfer of gastrin antiserum reduced LES pressure to approximately 20% of its basal level. The data provided by this study suggested that a smaller portion of basal LIES pressure was dependent upon adrenergic nerve function.
Initially, we felt that adrenergic nerve destruction with 6-hydroxydopamine would allow accurate quantification of that portion of LES pressure mediated through adrenergic nerves. However, the findings after 6-hydroxydopamine must be interpreted cautiously. First, the LES response to exogenous norepinephrine, but not to isoproterenol, was increased in sensitivity after 6-hydroxydopamine. Thus, any change in LES pressure after 6-hydroxydopamine might be modified by an increased responsiveness to circulating catecholamines. Second, it was possible that the 6-hydroxydopamine caused only partial a(drenergic nerve destruction. After 6-hydroxydopamine, LES pressure was reduced significantly by 22.5%. This reduction in pressure was less thani the 38.3% reduction seen with phentolamine in control animals. A remaining adrenergic-dependent component of LES pressure in the animals given 6-hydroxydopamine wvas demonstrated by the 18.6% further decrease in LES pressure w ith phentolamine. The design of this study did not distinguish directly whether the remaining adrenergic-dependent component of LES pressure after 6-hydroxydopamine was due to the acquired alpha adrenergic supersensitivity or to partial adrenergic nerve destruction. The question was approached by studying the response to tyramine and determining the norepinephlrine content of the distal esophagus. Tyranmine is an indirect-acting amine that acts to release norepinephrine from nerve terminals. The absenice of a response to tyramine has been used as an index of postganglionic denervationi or norepinephrine depletion by reserpine (17, 18) . In the animals given 6-hydroxydopamine, the LES response to tyramine was absent as compared to controls, suggesting a high degree of adrenergic nerve destruction. Further support was obtained by demonstrating that the norepinephrine content of the tissue was reduced to 4.6% of the control value. These studies suggest a high degree of adrenergic nerve destruction in 6-hydroxydopamine-treated animals but do not prove that the remaining adrenergic-dependent component of LES pressure in denervated animals is due to supersensitivity to circulating catecholamines.
The magnitude of the reduction in LES pressure by phentolamine in control and denervated animals suggested a greater effect of the adrenergic system in the genesis of LES pressure than would be predicted from the study utilizing gastrin antiserumii (15) . However, the possibility that phentolamine may have antagonist effects other than at alpha receptors could not be excluded (19) . Although the studies with phentolamine anid 6-hydroxVdopamine demonstrated a role for adrenergic nerves in the genesis of basal LES pressure, its exact quantification was difficult to establish. This study showed that adrenergic nerves did not cause relaxation of the LES during swallowing. After propranolol and denervation with 6-hydroxydopamine, LES relaxation was unaltered. This finding supported the observations in vitro suggesting that LES relaxation during swallowing was mediated through nonadrenergic inhibitory nerves (20) .
Although these studies were designed to evaluate the influence of adrenergic nerves on LES function, the intravenous administration of each adrenergic agonist and antagonist also affected cardiovascular function.
Changes in blood pressure were noted with each compound. The effect of these changes in blood pressure upon LES pressure was not readily ascertained. However, since blood pressure and LES pressure could be oppositely affected with certain compounds, change in LES pressure could not be attributed solely to alteration in blood pressure.
After 6-hydroxydopamine a change in sensitivity of the LES and blood pressure was recorded in response to norepinephrine but not isoproterenol. Adrenergic supersensitivity of nmuscle had been investigated extensivelv in the nictitating membrane of the cat but little work had been done onl gastrointestinal smooth muscle in vivo (17, 18) . The classical studies on adrenergic denervation indicated that there were two specific types of supersensitivity, preganglionic and postganglionic. Since 6-hydroxydopamine destroyed adrenergic nerve terminals, the postganglionic type was the most appropriate n1odel. Postganiglioinic denervation supersensitivity vas shown to appear 24 h after neural destruction and was characterized by clhanges in the dose response curve to an alplha adrenergic agonist. The entire curve was shifted to lower concentrations (i.e, to the left) but remained parallel to the control dose response curve. The maximum response was unchanged. In our studies, the norepinephrine dose response curves for LES and blood pressure were also shifted to the left, and the maximum response after denervation was also unchanged. Thus, the change in dose response characteristics after denervation strongly suggested supersensitivity to norepinephrine similar to that found by Trendelenburg in postganglionic denervation of the cat nictitating membrane (17, 18) . It was of interest that a change in sensitivity to isoproterenol after denervation was not noted. Failure to observe a change in sensitivity to adrenergic inhibition in the gastrointes-tinal tract had been reported previously (18, 21) . The change in sensitivity to norepinephrine after 6-hydroxydopamine as shown here provides the first evidence (to our knowledge) of adrenergic denervation supersensitivity in the esophagus.
The demonstration of the LES dose response characteristics of denervation supersensitivity to norepinephrine at 24-96 h after 6-hydroxydopamine further supported the presence of adrenergic nerve destruction within the esophagus. Although the dose response curves were constructed at the time of predicted maximum adrenergic nerve destruction by a single injection of 6-hvdroxydopamnine, this brief latent period probably did not allow the maximum development of supersensitivity (17, 18) . Postganglionic denervation supersensitivity appears at 24 h but maximum supersensitivity may not be achieved until 1-2 wk later. This is the time required for the additive effect of the small preganglionic (decentralization) component of supersensitivity. To study the prolonged effect of denervation, further studies would be required, using repeated doses of 6-hvdroxydopamine to maintain denervation. A comparison of the LES-norepinephrine dose response curve at 24-96 h with the curve obtained at the later date would then allow quantification of the added preganglionic component of supersensitivity.
